Stocks to Watch Thursday: Mattel, Cemex, Imsa, Vitro
| Jump to Sections Below | |
Mergers, acquisitions and joint ventures
Earnings/revenue reports and previews
Offerings and stock actions
Analyst actions
The drug sector saw a flurry of activity this morning as a number of analysts came out with comments on a number of stocks in the wake of Eli Lilly's (LLY Quote) early loss of patent protection for its blockbuster antidepressant drug Prozac. Credit Suisse First Boston cut estimates on Lilly with 2001 earnings-per-share estimates lowered to $2.84 from $3.05 and 2002 EPS views to $3.15 from $3.59. ABN Amro cut the stock to hold from outperform. Lehman Brothers cut Lilly's price target to 100 from 130 but maintained a buy rating on the stock. Meanwhile Morgan Stanley Dean Witter raised Lilly to outperform from neutral.Miscellany
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,471.58 | 1,108.86 | 2,175.81 | 32.75 |
Oil *
79.69
|
|
UP
126.74
|
UP
13.23
|
UP
31.21
|
UP
0.74
|
10 Yr
3.28%
SPDR Gold
117.38
|
|
+1.23%
|
+1.21%
|
+1.46%
|
+2.31%
|
Data delayed 20 minutes |














